Transcriptional mechanisms for the Wilms’ tumor gene 1 (WT1) oncoprotein

Organisational unit: Research group

Research areas and keywords

UKÄ subject classification

  • Cell and Molecular Biology



Acute leukemia occurs at all ages. Prognosis among adults is often poor and long term side effects remain serious problems after treatment of children. Perturbed transcriptional control is fundamental for the pathogenesis of leukemia, including defect function of the Wilms´ tumor gene 1 protein (WT1). Clinical, as well as experimental data indicate the transcription factor WT1 as an oncogene in leukemia. We hypothesize that certain isoforms of WT1, as well as leukemia-associated mutant forms, have specific DNA-binding properties. Thus isoform-imbalance, as well as mutations, can contribute to the leukemic phenotype. To seek support for this hypothesis, we will investigate the molecular function of different forms of WT1 genome-wide, as well as on specific target genes. Experimental models include primary hematopoietic cells, as well as transformed leukemic cell lines.

Recent research outputs

Ali, M., Ram Ajore, Anna Karin Wihlborg, Abhishek Niroula, Swaminathan, B., Ellinor Johnsson, Stephens, O. W., Morgan, G., Meissner, T., Ingemar Turesson, Goldschmidt, H., Mellqvist, U. H., Urban Gullberg, Markus Hansson, Kari Hemminki, Nahi, H., Waage, A., Weinhold, N. & Björn Nilsson, 2018 Dec 1, In : Nature Communications. 9, 1, 1649.

Research output: Contribution to journalArticle

Sodaro, G., Cesaro, E., Giorgia Montano, Blasio, G., Fiorentino, F., Romano, S., Jacquel, A., Aurberger, P. & Costanzo, P., 2018, In : Oncotarget. 9, 3, p. 3417-3431 15 p.

Research output: Contribution to journalArticle

View All (20)